Nausea and Vomiting Diagnosis and Management

Gastrointestinal Causes

• The American Gastroenterological Association recommends that bowel obstruction, a life-threatening condition, be diagnosed by abdominal distention, absent bowel sounds, and colicky pain 1
• Peptic ulcer disease can be excluded with upper endoscopy, according to the American College of Gastroenterology 1
• Gastroparesis, a condition affecting 20-40% of diabetic patients and 25-40% of functional dyspepsia patients, is diagnosed by gastric emptying scintigraphy performed for at least 2 hours, as recommended by the American Neurogastroenterology and Motility Society 2, 1
• Cyclic vomiting syndrome (CVS) has a prevalence of ~2% in US adults, characterized by stereotypical episodes of acute-onset vomiting, according to the American Gastroenterological Association 3, 1
• Cannabinoid hyperemesis syndrome (CHS) is a paradoxical cannabis-associated vomiting, with patients reporting need for hot water bathing to alleviate symptoms, as noted by the National Institute on Drug Abuse 4
• Functional dyspepsia is defined by Rome IV criteria as bothersome epigastric pain, burning, postprandial fullness, or early satiation without structural disease, according to the Rome Foundation 2
• Mechanical obstruction must be ruled out with upper endoscopy before diagnosing functional or motility disorders, as recommended by the American College of Gastroenterology 2
• Malignancy can be excluded by upper endoscopy, according to the American Cancer Society 1

Neurologic Causes

• Central nervous system tumors can cause nausea through increased intracranial pressure, as noted by the National Institute of Neurological Disorders and Stroke 1
• Increased intracranial pressure typically causes other neurologic signs, according to the American Academy of Neurology 1

Metabolic and Endocrine Causes

• Diabetic complications, such as hyperglycemia, can cause gastric dysmotility, as noted by the American Diabetes Association 2
• Thiamin deficiency should be evaluated in patients with persistent vomiting >2-3 weeks to prevent neurological complications, according to the National Institutes of Health 2

Medication and Toxin-Related Causes

• Opioid-induced nausea occurs in 10-50% of patients receiving opioids, which can worsen gastric emptying and should be avoided in gastroparesis patients, as recommended by the American Pain Society 1
• Chemotherapy-induced nausea and vomiting can be managed with antiemetic therapy, according to the American Society of Clinical Oncology 1
• Cannabis use is associated with CVS, CHS, and cannabinoid withdrawal syndrome (CWS), with a pooled prevalence of 47% in systematic review of 23,518 participants, as noted by the National Institute on Drug Abuse 4
• Cannabinoid withdrawal syndrome (CWS) occurs commonly on cessation of heavy and prolonged cannabis use, according to the Substance Abuse and Mental Health Services Administration 4

Psychiatric and Psychogenic Causes

• Psychogenic disorders should be considered when organic causes are excluded, as noted by the American Psychiatric Association 1
• Psychiatric comorbidity is associated with CVS, along with younger age and tobacco use, according to the National Institute of Mental Health 4

Diagnostic Pitfalls to Avoid

• Relying solely on symptoms can be misleading, as symptoms correlate poorly with degree of gastric emptying delay, as noted by the American Neurogastroenterology and Motility Society 2
• Failure to control blood glucose during testing can lead to false positive results, according to the American Diabetes Association 2
• Not accounting for medications affecting gastric emptying, such as prokinetics, opioids, and anticholinergics, can lead to inaccurate results, as recommended by the American College of Gastroenterology 2
• Shorter gastric emptying test durations (<2 hours) are inaccurate for determining gastroparesis, according to the American Neurogastroenterology and Motility Society 2
• Missing cannabis use history is critical for distinguishing CHS from CVS, as cannabis use augments hot water bathing behavior, as noted by the National Institute on Drug Abuse 4
• Overlooking eating behaviors, such as eating too quickly, insufficient chewing, and overeating, can cause postprandial vomiting, according to the Academy of Nutrition and Dietetics 2

Functional Dyspepsia and Vomiting

Introduction to Vomiting in Functional Dyspepsia

• The British Society of Gastroenterology guidelines state that delayed gastric emptying is more frequent in patients with early satiation, bloating, postprandial fullness, nausea, and vomiting, though this association is weak 5, 6
• The Rome IV criteria for functional dyspepsia include bothersome epigastric pain, burning, postprandial fullness, and early satiation as the core symptoms, with nausea as a supportive symptom, but vomiting warrants consideration of another disorder 7

Diagnostic Considerations

• Functional dyspepsia is indistinguishable from gastroparesis based on symptoms, gastric emptying testing, and pathological features, and both conditions may represent the same spectrum of gastric neuromuscular dysfunction 5, 6
• Delayed gastric emptying occurs in 25-40% of functional dyspepsia patients 8
• When vomiting is prominent in functional dyspepsia, it is likely dealing with the gastroparesis end of the spectrum 5, 6

Clinical Evaluation and Management

• The British Society of Gastroenterology recommends urgent endoscopy for patients aged ≥55 years with dyspepsia and weight loss, and non-urgent endoscopy for patients aged ≥55 years with treatment-resistant dyspepsia or dyspepsia with nausea/vomiting or raised platelet count 9, 10
• If vomiting is persistent or severe, do not simply accept functional dyspepsia as the diagnosis, and instead perform upper endoscopy to exclude mechanical obstruction, and consider gastric emptying scintigraphy for at least 4 hours 7
• Normal gastric retention at 4 hours is <10%, and gastroparesis is confirmed when retention is >10% 8

Diagnostic Approach for Early Satiety and Nausea

Primary Diagnostic Considerations

• The differential diagnosis for an adult with early satiety and nausea one hour after eating includes gastroparesis, functional dyspepsia, mechanical gastric outlet obstruction, peptic ulcer disease, and dumping syndrome, with gastroparesis and functional dyspepsia representing overlapping conditions on the same spectrum of gastric neuromuscular dysfunction, as recommended by the American Gastroenterological Association 11, 12
• Gastroparesis is indistinguishable from functional dyspepsia based on symptoms alone, and both may represent the same spectrum of pathological gastric neuromuscular dysfunction, according to the American Gastroenterological Association 11, 12
• Impaired fundic accommodation associates with reduced drinking capacity, early satiation, postprandial fullness, and weight loss, as reported by the European Society of Gastrointestinal Motility 11, 12
• Mechanical obstruction must be ruled out with upper endoscopy before diagnosing functional or motility disorders, as suggested by the Obesity Society 13
• Early dumping occurs within 30 minutes to 1 hour after eating in patients with prior gastric, esophageal, or bariatric surgery, presenting with cramp-like contractions, bloating, nausea, and vasomotor symptoms, according to the American Society for Metabolic and Bariatric Surgery 13

Diagnostic Testing

• Upper endoscopy is essential to rule out mechanical obstruction before diagnosing a functional or motility disorder, with diagnostic accuracy of 95%, as recommended by the American Society for Gastrointestinal Endoscopy 13
• Gastric emptying scintigraphy is the gold standard test for diagnosing gastroparesis, with sensitivity of 90% and specificity of 80%, as reported by the Society of Nuclear Medicine and Molecular Imaging 11, 12
• The test should be performed for at least 2 hours, with 4-hour testing providing higher diagnostic yield and accuracy, as suggested by the American Gastroenterological Association 11, 12
• Normal gastric retention at 4 hours is <10%; gastroparesis is confirmed when retention is >10% at 4 hours, according to the American Gastroenterological Association 11, 12
• Medications that influence gastric emptying should be withdrawn for 48-72 hours prior to testing, and blood glucose should be maintained in normal range during the test, as recommended by the American Diabetes Association 11, 12

Evaluation and Management of Upper‑Gastrointestinal Dyspepsia Symptoms

Epidemiology & Definition

• Functional dyspepsia (FD) affects up to 16 % of the adult population and accounts for ≈80 % of patients with burping, post‑prandial fullness, and nausea after investigative work‑up, making it the most common cause of these upper‑GI symptoms【14】【15】.
• The Rome IV criteria define FD as one or more bothersome epigastric pain, epigastric burning, post‑prandial fullness, or early satiation, with no structural disease on endoscopy【15】【16】.
• FD is subdivided into post‑prandial distress syndrome (PDS)—characterized by meal‑related fullness and early satiation—and epigastric pain syndrome (EPS)—characterized by epigastric pain or burning【15】【16】.
• Supportive symptoms frequently accompany FD, including excessive belching, post‑prandial bloating, and nausea【15】.

Major Differential Diagnoses

Gastroesophageal Reflux Disease (GERD)

• More than 50 % of GERD patients have no endoscopic esophagitis, rendering GERD clinically indistinguishable from FD in many cases【14】.
• Patients reporting heartburn or acid regurgitation ≥ once weekly should be managed as GERD until proven otherwise【14】.
• Significant symptom overlap exists between GERD and dyspepsia, complicating differentiation in uninvestigated patients【14】.

Peptic Ulcer Disease (PUD)

• PUD explains ≈10 % of upper‑GI symptom presentations in dyspeptic adults【14】.
• Principal risk factors are Helicobacter pylori infection (primary cause of non‑NSAID ulcers) and NSAID use【14】【15】.
• Upper endoscopy is required to definitively diagnose or exclude PUD【14】.

Gastric or Esophageal Malignancy

• In adults ≥55 years presenting with alarm features, malignancy must be considered and investigated promptly【14】【17】.

Medication‑Induced Dyspepsia

• Dyspeptic symptoms can be precipitated or worsened by NSAIDs, opioids, and anticholinergic agents【15】.

Alarm Features & Indications for Endoscopy

• Age ≥ 55 years with any alarm feature mandates upper endoscopy【17】【18】. Specific alarm criteria include:
  
  • Unexplained weight loss – urgent 2‑week wait endoscopy【17】.
  • Treatment‑resistant dyspepsia – non‑urgent endoscopy【17】.
  • Dyspepsia accompanied by nausea/vomiting or elevated platelet count – non‑urgent endoscopy【17】.
  • Dysphagia at any age – urgent endoscopy【17】.
  • Haematemesis – non‑urgent endoscopy【17】.
  • Upper abdominal mass – 2‑week outpatient referral【17】.

Diagnostic Algorithm

Initial Clinical Assessment

• Detailed symptom history focusing on meal timing, symptom duration (>6 months favors FD), and presence of alarm features is essential【17】【18】.
• Systematic assessment of risk factors (female sex, smoking, NSAID use, H. pylori infection, psychological comorbidity, recent gastroenteritis, diabetes, prior gastric surgery) guides further testing【15】.
• Medication review for opioids, NSAIDs, and anticholinergics should be performed【15】.

Age & Alarm Feature Stratification

• Patients <55 years without alarm features: adopt an H. pylori test‑and‑treat strategy, followed by empirical high‑dose PPI therapy if symptoms persist【14】.
• Patients ≥55 years or any age with alarm features: perform upper endoscopy before confirming FD【14】【17】【18】.

H. pylori Testing & Treatment (for eligible patients)

• Preferred non‑invasive tests are the 13C‑urea breath test or stool antigen assay【14】.
• Eradication therapy is the only intervention demonstrated to modify the natural history of FD【14】.
• If H. pylori testing is negative or symptoms persist after eradication, initiate an empirical PPI trial for 4–8 weeks【14】.

Consideration of Gastroparesis

• Persistent vomiting should prompt evaluation for gastroparesis, as Rome IV criteria consider vomiting a red flag for disorders beyond FD【15】.

Initial Management While Awaiting Definitive Work‑up

• Initiate empirical high‑dose PPI therapy (e.g., omeprazole 20–40 mg once daily before meals) for suspected acid‑related pathology【15】.
• Counsel patients on modifiable risk factors: smoking cessation, avoidance of NSAIDs when possible, and stress‑reduction strategies【15】.

Common Pitfalls to Avoid

• Do not diagnose FD without endoscopy in adults ≥55 years or those with alarm features; structural disease must be excluded first【15】【16】.
• Do not attribute persistent or severe vomiting to FD; such presentation warrants further investigation per Rome IV criteria【15】.
• Do not overlook medication‑induced dyspepsia; opioids, NSAIDs, and anticholinergics are frequent contributors【15】.

Management and Diagnostic Guidelines for Intermittent Loss of Appetite and Post‑Prandial Vomiting

Diagnostic Alarm Features

Pharmacologic Therapy for Functional Dyspepsia / Gastroparesis

Antiemetic Strategies

Advanced Management of Refractory Cases